Navigation Links
Duke develops nano-scale drug delivery for chemotherapy
Date:11/1/2009

DURHAM, N.C. -- Going smaller could bring better results, especially when it comes to cancer-fighting drugs.

Duke University bioengineers have developed a simple and inexpensive method for loading cancer drug payloads into nano-scale delivery vehicles and demonstrated in animal models that this new nanoformulation can eliminate tumors after a single treatment. After delivering the drug to the tumor, the delivery vehicle breaks down into harmless byproducts, markedly decreasing the toxicity for the recipient.

Nano-delivery systems have become increasingly attractive to researchers because of their ability to efficiently get into tumors. Since blood vessels supplying tumors are more porous, or leaky, than normal vessels, the nanoformulation can more easily enter and accumulate within tumor cells. This means that higher doses of the drug can be delivered, increasing its cancer-killing abilities while decreasing the side effects associated with systematic chemotherapy

"When used to deliver anti-cancer medications in our models, the new formulation has a four-fold higher maximum tolerated dose than the same drug by itself, and it induced nearly complete tumor regression after one injection," said Ashutosh Chilkoti, Theo Pilkington Professor of Biomedical Engineering at Duke's Pratt School of Engineering. "The free drug had only a modest effect in shrinking tumors or in prolonging animal survival".

The results of Chilkoti's experiments were published early online in the journal Nature Materials.

"Just as importantly, we believe, is the novel method we developed to create these drugs," Chilkoti said. "Unlike other approaches, we can produce large quantities simply and inexpensively, and we believe the new method theoretically could be used to improve the effectiveness of other existing cancer drugs."

Central to the new method is how the drug is "attached" to its polypeptide delivery system and whether or not
'/>"/>

Contact: Richard Merritt
richard.merritt@duke.edu
919-660-8414
Duke University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. GSU professor develops new method to help keep fruit, vegetables and flowers fresh
2. Epigentek Develops a New Method of Measuring Global DNA Methylation
3. Carnegie Mellon develops innovative method to detect genetic causes of complex diseases
4. HudsonAlpha investigator develops rapid response swine flu test
5. CSHL team develops mouse models of leukemia that predict response to chemotherapy
6. MIT student develops new innovations to selectively kill cancer cells
7. When acute hepatitis develops into chronic hepatitis
8. Fujitsu Develops HDD Security Technology Based on Opal SSC Standards
9. MIT develops new way to fuse cells
10. Hypertension develops early, silently, in African-American men
11. Iowa State researcher develops new treatment method for canine eye diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Duke develops nano-scale drug delivery for chemotherapy
(Date:8/20/2014)... have discovered that acral melanomas the rare type of ... are genetically distinct from other more common types of skin ... the journal Pigment Cell & Melanoma Research . , ... soles of the feet, nail-beds and other hairless parts of ... not caused by UV damage from the sun. , The ...
(Date:8/20/2014)... rugs and plastic bags could one day be made ... petroleum, scientists are now reporting. The novel process they ... deal with its agricultural and plastic waste problems, appear ... Athanassiou, Ilker S. Bayer and colleagues at the Italian ... constantly growing. In 2012, its production reached 288 million ...
(Date:8/20/2014)... (PS1) absorbs light and its energy is finally ... biomass. Photovoltaic devices, mostly build from silicon based ... One approach for the development of cheaper and ... the isolated membrane protein complexes of photosynthesis. Prof. ... PS1 from thermophilic cyanobacteria that live in a ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2A semi-artificial leaf faster than 'natural' photosynthesis 2
... -- A new study led by Florida State University ... more flowers in response to only slight increases in ... clouds and rainfall affect the number of flowers that ... an effect over short-term seasonal growth, but longer-term changes ...
... Small and large-scale farmers in Riau province, Sumatra, have ... and parts of Malaysia. But scientists in Indonesia have ... buy unregulated access to land for oil palm and ... Scientists at the World Agroforestry Centre, who have been ...
... 8 July 2013: Egg donation is now one of ... treatment. Because this growing trend may circumvent regulations at ... also become one of the most controversial. Yet little ... eggs in overseas clinics - their characteristics, their motivation ...
Cached Biology News:Temperature increases causing tropical forests to blossom, according to study 2Less haze in Singapore as the cause becomes clearer and more complex 2Egg donation in European clinics: Why do women do it? 2Egg donation in European clinics: Why do women do it? 3
(Date:8/18/2014)... Aug. 18, 2014 BioElectronics Corporation ... consumer medical devices said that its EVP ... by CEOLIVE.TV as part of its Executive ... is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel ... to investors the unique advantages of BioElectronics ...
(Date:8/18/2014)... UPTON, NYElectronic devices with unprecedented efficiency and ... materials that use built-in electric polarizations to ... magnets inside most popular data-driven technology. But ... stumbling blocks, including a curious habit of ... at the U.S. Department of Energy,s Brookhaven ...
(Date:8/18/2014)... YORK , August 18, 2014 ... published by Transparency Market Research "Life Science Reagents ... Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and ... and Academic Institutions, Clinical Laboratories, and Forensic Laboratories)- ... Forecast, 2013 - 2019", the global life science ...
(Date:8/18/2014)... Aug. 18, 2014 TNI BioTech, Inc. (OTC-BB: ... the manufacturing and marketing of innovative therapies for autoimmune ... is providing a second notice of TNI BioTech,s annual ... the announcement, Noreen Griffin , founder and CEO ... for your participation in the Annual Meeting. On behalf ...
Breaking Biology Technology:BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4
... (TSX: GEN),a company focused on developing molecular diagnostic ... early detection of diseases and personalized,health management, today ... design and development of in-vitro diagnostic (IVD) test,kits ... in a laboratory,setting, has met the requirements of ...
... Sweden, March 11 Mentice AB, a leading,supplier of ... has recently appointed James Ruscoe as Chairman of the ... Mr. Ruscoe graduated from Oxford University and brings ... He also serves as CEO and,board member of several ...
... March 11 Proteome Systems Ltd. (ASX: PXL),CEO ... a panel with world health,leaders in Washington DC ... the Bill & Melinda Gates Foundation and organised ... Biotechnology Industry Organization.,[March 10-12, 2008]., http://pgh.bio.org/opencms/PGH/2008/program/program.jsp , ...
Cached Biology Technology:GeneNews receives ISO 13485 accreditation 2Mentice AB Announces Leadership Changes Within Its Worldwide Operations 2The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems' CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C. 2The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems' CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C. 3
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
Red Standard is sodium salt of resorufin....
X-Gal, 100 mg. 5-Bromo-4-chloro-3-indolyl-b-d-galactoside.Histochemical substrate for b-galactosidase, used in blue/white screening.Store at -20 C. Protect from moisture. Category: Nucleotides & Enzy...
Biology Products: